@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_head { this: np:hasAssertion dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_assertion; np:hasProvenance dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_provenance; np:hasPublicationInfo dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_publicationInfo; a np:Nanopublication . dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_assertion a np:Assertion . dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_provenance a np:Provenance . dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_publicationInfo a np:PublicationInfo . } dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_assertion { miriam-gene:5443 a ncit:C16612 . lld:C0852654 a ncit:C7057 . dgn-gda:DGNc979977c5b81e3ec31da4b5e912466fd sio:SIO_000628 miriam-gene:5443, lld:C0852654; a sio:SIO_001121 . } dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_provenance { dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_assertion dcterms:description "[When possible, we will try to achieve this goal also by providing some results from our personal experience regarding: some aspects of CYP21A2 gene analysis, with basic genotype/phenotype relationships; its crucial role in both genetic counselling and in prenatal diagnosis and treatment in families at risk for 21-OHD; its help in the comprehension of the severity of the disease in patients diagnosed by neonatal screening and possibly treated before an evident salt-loss crisis or before performing adequate blood sampling; its usefulness in the definition of post ACTH 17-hydroxyprogesterone values, discriminating between non-classic, heterozygote and normal subjects; and finally the contribution of genes other than CYP21A2 whose function or dysfunction could influence 21-hydroxylase activity and modify the presentation or management of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:20639616; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP826769.RA8fyUll26C6eTw9VIn4LLXXLlp81m3LOZvXriS9pdZmQ130_publicationInfo { this: dcterms:created "2016-05-13T12:47:59+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }